Rbc Life Sciences 8 K Form Page 5
ADVERTISEMENT
1
2
3
4
5Page 2
RBC Life Sciences, Inc.
Summary Results of Operations
(in thousands, except per share data)
(unaudited)
Quarters Ended September 30,
2012
2011
Net sales
$
6,713
$
7,061
Gross profit
3,071
3,318
Operating profit (loss)
(525)
(486)
Earnings (loss) before income taxes
(556)
(521)
Provision (benefit) for income taxes
(233)
(231)
Net earnings (loss)
(323)
(290)
Earnings (loss) per share - basic
$
(0.01)
$
(0.01)
Earnings (loss) per share - diluted
(0.01)
(0.01)
Weighted average shares outstanding - basic
22,229
22,229
Weighted average shares outstanding - diluted
22,229
22,229
RBC Life Sciences, Inc.
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
September 30,
December 31,
2012
2011
Assets
Cash and cash equivalents
$
2,917
$
3,859
Inventories
5,565
6,449
Other current assets
2,225
1,669
Total current assets
10,707
11,977
Other assets
6,584
6,849
Total assets
$
17,291
$
18,826
Liabilities and shareholders' equity
Accounts payable and accrued liabilities
$
2,740
$
3,237
Deferred revenue
2,510
2,990
Other current liabilities
193
182
Total current liabilities
5,443
6,409
Other liabilities
2,350
2,554
Shareholders' equity
9,498
9,863
Total liabilities and shareholders' equity
$
17,291
$
18,826
ADVERTISEMENT
0 votes
Related Articles
Related forms
Related Categories
Parent category: Legal